Medshine Discovery Inc.
64Patents
63Active
64Granted
55Portfolio score
Filing activity: Aug 18, 2014 → Aug 30, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9969719B2 | Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug | Chemistry; Metallurgy | 8 | Active |
| US10519133B2 | Vinyl compounds as FGFR and VEGFR inhibitors | Chemistry; Metallurgy | 3 | Active |
| US9856264B2 | Isoquinolinesulfonyl derivative as RHO kinase inhibitor | Chemistry; Metallurgy | 2 | Active |
| US11433053B2 | LSD1 inhibitor and preparation method and application thereof | Chemistry; Metallurgy | 2 | Active |
| US11117899B2 | [1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor | Human Necessities | 2 | Active |
| US9856262B2 | Analogues of 4H-pyrazolo[1,5-a] benzimidazole compound as PARP inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11623923B2 | Uracil compound as c-MET/AXL inhibitor | Chemistry; Metallurgy | 1 | Active |
| US11459323B2 | Monocyclic β-lactam compound for treating bacterial infection | Human Necessities | 1 | Active |
| US10647710B2 | Thiazole derivative and applications thereof | Chemistry; Metallurgy | 1 | Active |
| US10633351B2 | Halogenated compound and axially chiral isomer thereof | Chemistry; Metallurgy | 1 | Active |
| US10532986B2 | Cyclic compound acting as PDE4 inhibitor | Chemistry; Metallurgy | 1 | Active |
| US11691974B2 | 3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors | Human Necessities | 1 | Active |
| US10981860B2 | Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof | Chemistry; Metallurgy | 1 | Active |
| US11345678B2 | Benzopyrazole compound used as RHO kinase inhibitor | Chemistry; Metallurgy | 1 | Active |
| US10717720B2 | Modified compound of andrographolide | Chemistry; Metallurgy | 1 | Active |
| US10548883B2 | Benzotriazole-derived α and β-unsaturated amide compound used as TGF-β RI inhibitor | Chemistry; Metallurgy | 1 | Active |
| US11649239B2 | Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1) | Chemistry; Metallurgy | 0 | Active |
| US11655248B2 | Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor | Chemistry; Metallurgy | 0 | Active |
| US11466024B2 | Bicylic compound acting as an inhibitor | Chemistry; Metallurgy | 0 | Active |
| US11384065B2 | Heterocyclic compound as CSF-1R inhibitor and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11352331B2 | Crystal and salt of 4-(naphthalen-1-yl)-4H-1,2,4-triazole compound and preparation method therefor | Chemistry; Metallurgy | 0 | Active |
| US11377444B2 | Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10280229B2 | Linkers and their application towards ADC | Chemistry; Metallurgy | 0 | Active |
| US11319330B2 | Tricyclic furan-substituted piperidinedione compound | Chemistry; Metallurgy | 0 | Active |
| US10851112B2 | Anti-HCMV virus compound | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.